PIMA530007
Influenza A HA Recombinant Rabbit Monoclonal Antibody (133), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA530007-Each-of-1 | In Stock | ₹ 50,596.50 |
PIMA530007 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 50,596.50
GST (18%): ₹ 9,107.37
Total Price: ₹ 59,703.87
Antigen
Influenza A HA
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with no preservative
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Applications
ELISA, Western Blot
Clone
133
Conjugate
Unconjugated
Gene Alias
flu hemagglutinin; influenza hemagglutinin
Immunogen
Recombinant H1N1 HA protein
Quantity
100μL
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- This product is preservative free
- It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%)
- Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems
- The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits
- Then, individual clones are screened to select the best candidates for production
- The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire
- This antibody has specificity for H1N1 (A/California/04/2009) HA H1N1 (A/California/07/2009) HA
- Infectious diseases are the leading cause of death worldwide
- AIDS, tuberculosis (TB), malaria, diarrhoeal and respiratory infections account for 78% of deaths caused by infectious disease
- As many infectious diseases are controlled, new diseases emerge and old diseases become resistant to current drugs
- Many infectious diseases have been associated with an increase risk of carcinoma
- Influenza continues to attract researchers as new strains appear by the ability of the influenza gene to mix with different forms of the virus
- Recently, research on SARS and West Nile virus has risen due to the increased number of infections
- These antibodies assist in research by detecting the infectious disease agent.